{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:24:41Z","timestamp":1790270681648,"version":"4.1.0"},"reference-count":103,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health\u2014Ricerca Corrente 2025","award":["RRC-2025-23686388"],"award-info":[{"award-number":["RRC-2025-23686388"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>Background: Alzheimer\u2019s Disease (AD) is the most common form of dementia and is characterized by progressive cognitive decline and neurodegeneration. In Italy, AD represents a major public health and socio-economic challenge. This review aims to summarize current Italian research on pharmacological and non-pharmacological interventions, including preclinical studies, clinical trials, rehabilitative approaches, and emerging neuromodulation techniques, highlighting contributions and future directions. Methods: A narrative review of the literature was conducted, focusing on Italian preclinical and clinical studies, observational and real-world evidence, cognitive and physical interventions, music therapy, non-invasive brain stimulation (rTMS, tDCS, tACS), and digital or home-based rehabilitation programs. Results: Italian research has explored different pharmacological strategies, including multitarget compounds, eptastigmine, rotigotine, and combinatorial therapies (donepezil-memantine, citicoline addition). Non-pharmacological interventions, such as cognitive stimulation, motor rehabilitation, music therapy, and multidimensional programs, demonstrated benefits on cognition, behavior, daily functioning, and caregiver well-being. Non-invasive neuromodulation techniques, targeting the dorsolateral prefrontal cortex and precuneus, showed promising effects on memory, attention, and executive functions, especially when combined with cognitive training. Digital health technologies, including telerehabilitation and home-based brain stimulation programs, further enhanced accessibility and adherence. Challenges remain due to fragmented research, small sample sizes, and limited standardization. Conclusions: Italian research on AD reflects a growing emphasis on integrated, multidimensional, and technologically advanced approaches. Strengthening preclinical studies, promoting multicenter collaborations, and combining pharmacological, cognitive, and neuromodulatory strategies may enhance therapeutic efficacy and patient quality of life. Continued investment in innovation and multidisciplinary research positions Italy to contribute meaningfully to global AD management and prevention.<\/jats:p>","DOI":"10.3390\/neurolint17120196","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:39:43Z","timestamp":1764679183000},"page":"196","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Research on Alzheimer Disease in Italy: A Narrative Review of Pharmacological and Non-Pharmacological Interventions"],"prefix":"10.3390","volume":"17","author":[{"given":"Miriana","family":"Caporlingua","sequence":"first","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Palermo S.S. 113, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jole","family":"Castellano","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Palermo S.S. 113, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Quartarone","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Palermo S.S. 113, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0709-5914","authenticated-orcid":false,"given":"Rosella","family":"Ciurleo","sequence":"additional","affiliation":[{"name":"IRCCS Centro Neurolesi \u201cBonino-Pulejo\u201d, Via Palermo S.S. 113, Contrada Casazza, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-94-007-5416-4_14","article-title":"Alzheimer\u2019s disease","volume":"65","author":"Radanovic","year":"2012","journal-title":"Subcell. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hillen, H. (2019). The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer\u2019s Disease. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.01154"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2006-956753","article-title":"Alzheimer\u2019s disease","volume":"Volume 27","author":"Yaari","year":"2007","journal-title":"Seminars in Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","article-title":"Clinical aspects of Alzheimer\u2019s disease","volume":"72","year":"2019","journal-title":"Clin. Biochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"b158","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer\u2019s disease","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13073-015-0232-5","article-title":"The age factor in Alzheimer\u2019s disease","volume":"7","author":"Guerriero","year":"2015","journal-title":"Genome Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chatterjee, S., and Mudher, A. (2018). Alzheimer\u2019s Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00383"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"de Bruijn, R.F., and Ikram, M.A. (2014). Cardiovascular risk factors and future risk of Alzheimer\u2019s disease. BMC Med., 12.","DOI":"10.1186\/s12916-014-0130-5"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/acschemneuro.9b00607","article-title":"Association of Intestinal Disorders with Parkinson\u2019s Disease and Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"11","author":"Fu","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Santiago, J.A., and Potashkin, J.A. (2021). The Impact of Disease Comorbidities in Alzheimer\u2019s Disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.631770"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","article-title":"Drug treatments in Alzheimer\u2019s disease","volume":"16","author":"Briggs","year":"2016","journal-title":"Clin. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., and Karaman, R. (2020). Comprehensive review on Alzheimer\u2019s disease: Causes and treatment. Molecules, 25.","DOI":"10.3390\/molecules25245789"},{"key":"ref_15","first-page":"1479","article-title":"Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (Review)","volume":"20","author":"Sharma","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A review on cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: Targeting the cholinergic system","volume":"14","author":"Guimaraes","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, J., Chang, L., Song, Y., Li, H., and Wu, Y. (2019). The role of NMDA receptors in Alzheimer\u2019s disease. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00043"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/157015912803217288","article-title":"NMDA neurotransmission dysfunction in behavioral and psychological symptoms of Alzheimer\u2019s disease","volume":"10","author":"Huang","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"ref_21","first-page":"109","article-title":"Defining disease modifying therapy for Alzheimer\u2019s disease","volume":"4","author":"Cummings","year":"2017","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1179573520907397","DOI":"10.1177\/1179573520907397","article-title":"Current and future treatments in Alzheimer disease: An update","volume":"12","author":"Yiannopoulou","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2125.2011.04134.x","article-title":"New pharmacological strategies for treatment of Alzheimer\u2019s disease: Focus on disease modifying drugs","volume":"73","author":"Salomone","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wang, L.Y., Pei, J., Zhan, Y.J., and Cai, Y.W. (2020). Overview of meta-analyses of five non-pharmacological interventions for Alzheimer\u2019s disease. Front. Aging Neurosci., 12.","DOI":"10.3389\/fnagi.2020.594432"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000316119","article-title":"Nonpharmacological therapies in Alzheimer\u2019s disease: A systematic review of efficacy","volume":"30","author":"Reisberg","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_26","unstructured":"World Health Organization (WHO) (2025, October 09). Dementia. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"ref_27","unstructured":"Alzheimer\u2019s Disease International (2025, October 09). Dementia Statistics. Available online: https:\/\/www.alzint.org\/about\/dementia-facts-figures\/dementia-statistics."},{"key":"ref_28","unstructured":"Istituto Superiore di Sanit\u00e0 (2025, October 09). Informazioni Generali. Available online: https:\/\/www.epicentro.iss.it\/alzheimer."},{"key":"ref_29","unstructured":"Ministero Della Salute (2025, October 09). Dati Epidemiologici, Available online: https:\/\/www.salute.gov.it\/new\/it\/tema\/demenze\/dati-epidemiologici."},{"key":"ref_30","unstructured":"ISTAT (2025, October 09). Rapporto Annuale 2025. Available online: https:\/\/www.istat.it\/wp-content\/uploads\/2025\/05\/Rapporto-Annuale-2025-integrale.pdf."},{"key":"ref_31","unstructured":"Istituto Superiore di Sanit\u00e0 (2025, October 09). Archivio 2020\u20132024. Available online: https:\/\/www.epicentro.iss.it\/demenza\/2020-2024."},{"key":"ref_32","unstructured":"Ministero Della Salute (2025, October 09). Giornata Mondiale dell\u2019Alzheimer 2024, Available online: https:\/\/www.salute.gov.it\/new\/it\/news-e-media\/notizie\/giornata-mondiale-dellalzheimer-2024."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/cmdc.201500392","article-title":"Multitarget strategy to address Alzheimer\u2019s disease: Design, synthesis, biological evaluation, and computational studies of coumarin-based derivatives","volume":"11","author":"Montanari","year":"2016","journal-title":"ChemMedChem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Carocci, A., Barbarossa, A., Leuci, R., Carrieri, A., Brunetti, L., Laghezza, A., Catto, M., Limongelli, F., Chaves, S., and Tortorella, P. (2022). Novel phenothiazine\/donepezil-like hybrids endowed with antioxidant activity for a multi-target approach to the therapy of Alzheimer\u2019s disease. Antioxidants, 11.","DOI":"10.3390\/antiox11091631"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12974-019-1417-4","article-title":"Anti-inflammatory and cognitive effects of interferon-\u03b21a (IFN\u03b21a) in a rat model of Alzheimer\u2019s disease","volume":"16","author":"Frinchi","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000017208","article-title":"A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer\u2019s disease","volume":"11","author":"Imbimbo","year":"2000","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2012.07.015","article-title":"Dopamine D2-agonist rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer\u2019s disease patients","volume":"64","author":"Martorana","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1038\/npp.2014.119","article-title":"Dopaminergic modulation of cortical plasticity in Alzheimer\u2019s disease patients","volume":"39","author":"Koch","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e2010372","DOI":"10.1001\/jamanetworkopen.2020.10372","article-title":"Effect of rotigotine vs placebo on cognitive functions among patients with mild to moderate Alzheimer disease","volume":"3","author":"Koch","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-11-30","article-title":"A pilot study on the use of interferon beta-1a in early Alzheimer\u2019s disease subjects","volume":"11","author":"Grimaldi","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.50.4.996","article-title":"Estrogen-replacement therapy and Alzheimer\u2019s disease in the Italian Longitudinal Study on Aging","volume":"50","author":"Baldereschi","year":"1998","journal-title":"Neurology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3233\/JAD-201211","article-title":"A retrospective study on the benefits of combined citicoline, memantine, and acetylcholinesterase inhibitor treatments in older patients affected with Alzheimer\u2019s disease","volume":"79","author":"Castagna","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/03007995.2023.2182530","article-title":"Extemporaneous combination of donepezil and memantine to treat dementia in Alzheimer disease: Evidence from Italian real-world data","volume":"39","author":"Padovani","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1034\/j.1600-0404.2002.01086.x","article-title":"Comparing two programs of cognitive training in Alzheimer\u2019s disease: A pilot study","volume":"105","author":"Farina","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/13607860500409492","article-title":"Evaluating two group programmes of cognitive training in mild-to-moderate AD: Is there any difference between a \u2018global\u2019 stimulation and a \u2018cognitive-specific\u2019 one?","volume":"10","author":"Farina","year":"2006","journal-title":"Aging Ment. Health"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1545968314532833","article-title":"Multistimulation group therapy in Alzheimer\u2019s disease promotes changes in brain functioning","volume":"29","author":"Baglio","year":"2015","journal-title":"Neurorehabil. Neural Repair"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/1533317511418956","article-title":"Six-month walking program changes cognitive and ADL performance in patients with Alzheimer","volume":"26","author":"Venturelli","year":"2011","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Dement."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1533317512459794","article-title":"From Alzheimer\u2019s disease retrogenesis: A new care strategy for patients with advanced dementia","volume":"27","author":"Venturelli","year":"2012","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Dement."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10072-018-3316-3","article-title":"Combining drug and music therapy in patients with moderate Alzheimer\u2019s disease: A randomized study","volume":"39","author":"Giovagnoli","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.18632\/aging.101970","article-title":"Comparison between physical and cognitive treatment in patients with MCI and Alzheimer\u2019s disease","volume":"11","author":"Fonte","year":"2019","journal-title":"Aging"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Millet, B., Mouchabac, S., Robert, G., Maatoug, R., Dondaine, T., Ferreri, F., and Bourla, A. (2023). Transcranial magnetic stimulation (rTMS) on the precuneus in Alzheimer\u2019s disease: A literature review. Brain Sci., 13.","DOI":"10.3390\/brainsci13091332"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.gerinurse.2024.07.013","article-title":"Systematic review and meta-analysis of transcranial direct current stimulation (tDCS) for global cognition in mild cognitive impairment and Alzheimer\u2019s disease","volume":"59","author":"Hou","year":"2024","journal-title":"Geriatr. Nurs."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40035-024-00423-y","article-title":"Transcranial alternating current stimulation (tACS) at gamma frequency: An up-and-coming tool to modify the progression of Alzheimer\u2019s disease","volume":"13","author":"Paoletti","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.rehab.2015.05.005","article-title":"Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS)","volume":"58","author":"Klomjai","year":"2015","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s002210000432","article-title":"Interindividual variability of the modulatory effects of repetitive transcranial magnetic stimulation on cortical excitability","volume":"133","author":"Maeda","year":"2000","journal-title":"Exp. Brain Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.clinph.2021.05.035","article-title":"Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia","volume":"132","author":"Bella","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13195-018-0423-6","article-title":"The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease","volume":"10","author":"Benussi","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2019.08.020","article-title":"A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer\u2019s disease","volume":"86","author":"Chou","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/jnnp.2009.197848","article-title":"Improved language performance in Alzheimer disease following brain stimulation","volume":"82","author":"Cotelli","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3233\/JAD-190888","article-title":"Low-frequency repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex enhances recognition memory in Alzheimer\u2019s disease","volume":"72","author":"Turriziani","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jns.2019.01.038","article-title":"The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"398","author":"Lin","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neuroimage.2017.12.048","article-title":"Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer\u2019s disease","volume":"169","author":"Koch","year":"2018","journal-title":"Neuroimage"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/brain\/awac285","article-title":"Precuneus magnetic stimulation for Alzheimer\u2019s disease: A randomized, sham-controlled trial","volume":"145","author":"Koch","year":"2022","journal-title":"Brain"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13195-025-01709-7","article-title":"Effects of 52 weeks of precuneus rTMS in Alzheimer\u2019s disease patients: A randomized trial","volume":"17","author":"Koch","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.brs.2020.09.010","article-title":"Enhancing cognitive training effects in Alzheimer\u2019s disease: rTMS as an add-on treatment","volume":"13","author":"Bagattini","year":"2020","journal-title":"Brain Stimul."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11357-021-00508-w","article-title":"Neuronavigated magnetic stimulation combined with cognitive training for Alzheimer\u2019s patients: An EEG graph study","volume":"44","author":"Vecchio","year":"2022","journal-title":"Geroscience"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/WNP.0b013e31802fa393","article-title":"Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils","volume":"24","author":"Roth","year":"2007","journal-title":"J. Clin. Neurophysiol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Leocani, L., Dalla Costa, G., Coppi, E., Santangelo, R., Pisa, M., Ferrari, L., Bernasconi, M.P., Falautano, M., Zangen, A., and Magnani, G. (2021). Repetitive transcranial magnetic stimulation with H-coil in Alzheimer\u2019s disease: A double-blind, placebo-controlled pilot study. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.614351"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.brs.2023.04.001","article-title":"The impact of gamma transcranial alternating current stimulation (tACS) on cognitive and memory processes in patients with mild cognitive impairment or Alzheimer\u2019s disease: A literature review","volume":"16","author":"Nissim","year":"2023","journal-title":"Brain Stimul."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.brs.2021.03.007","article-title":"Exposure to gamma tACS in Alzheimer\u2019s disease: A randomized, double-blind, sham-controlled, crossover, pilot study","volume":"14","author":"Benussi","year":"2021","journal-title":"Brain Stimul."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ana.26411","article-title":"Increasing brain gamma activity improves episodic memory and restores cholinergic dysfunction in Alzheimer\u2019s disease","volume":"92","author":"Benussi","year":"2022","journal-title":"Ann. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1113\/jphysiol.2013.270280","article-title":"Transcranial cerebellar direct current stimulation and transcutaneous spinal cord direct current stimulation as innovative tools for neuroscientists","volume":"592","author":"Priori","year":"2014","journal-title":"J. Physiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/01.wnl.0000317060.43722.a3","article-title":"Transcranial direct current stimulation improves recognition memory in Alzheimer disease","volume":"71","author":"Ferrucci","year":"2008","journal-title":"Neurology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.brs.2011.06.006","article-title":"Prolonged visual memory enhancement after direct current stimulation in Alzheimer\u2019s disease","volume":"5","author":"Boggio","year":"2012","journal-title":"Brain Stimul."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Cotelli, M., Manenti, R., Brambilla, M., Petesi, M., Rosini, S., Ferrari, C., Zanetti, O., and Miniussi, C. (2014). Anodal tDCS during face-name associations memory training in Alzheimer\u2019s patients. Front. Aging Neurosci., 6.","DOI":"10.3389\/fnagi.2014.00038"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Fonte, C., Rotundo, G., Varalta, V., Filosa, A., Muti, E., Barletta, C., Evangelista, E., Venturelli, M., Picelli, A., and Smania, N. (2024). Combined effect of tDCS and motor or cognitive activity in patients with Alzheimer\u2019s disease: A proof-of-concept pilot study. Brain Sci., 14.","DOI":"10.20944\/preprints202407.2108.v1"},{"key":"ref_77","unstructured":"Fondazione Policlinico Universitario Agostino Gemelli (2025, October 09). Clinicaltrials.gov, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06372587."},{"key":"ref_78","unstructured":"I.R.C.C.S. Fondazione Santa Lucia (2025, October 09). Clinicaltrials.gov. A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer\u2019s Disease (DOPAD-3), Available online: https:\/\/clinicaltrials.gov\/study\/NCT06702124."},{"key":"ref_79","unstructured":"I.R.C.C.S. Fondazione Santa Lucia (2025, October 09). Clinicaltrials.gov. Fundus Camera Module for Early Detection of Alzheimer\u2019s Disease, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06841848."},{"key":"ref_80","unstructured":"Alemanno, F. (2025, October 09). Ospedale San Raffaele. Clinicaltrials.gov. New Virtual Reality Technologies and Telemedicine for Cognitive Rehabilitation in Alzheimer\u2019s Disease (TaskCog-IVN), Available online: https:\/\/clinicaltrials.gov\/study\/NCT05697354."},{"key":"ref_81","unstructured":"Venturelli, M. (2025, October 09). Universit\u00e0 di Verona. Clinicaltrials.gov. New Approach for Treatment of Behavioral Disorders in Alzheimer\u2019s Disease (Alzheimer\u2019s Behavioral and Cognitive Disorders) (ABCD), Available online: https:\/\/clinicaltrials.gov\/study\/NCT02462291."},{"key":"ref_82","unstructured":"De Lena, C. (2025, October 09). Universit\u00e0 di Roma La Sapienza. Clinicaltrials.gov. Neuropsychological and Neurophysiological Effects of Cognitive Stimulation in Patients with Alzheimer\u2019s Disease and Mild Cognitive Impairment, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03784183."},{"key":"ref_83","unstructured":"Koch, G., and I.R.C.C.S. Fondazione Santa Lucia (2025, October 09). Clinicaltrials.gov. Digital Twins for Model-Driven Non-Invasive Electrical Brain Stimulation (NEUROTWIN), Available online: https:\/\/clinicaltrials.gov\/study\/NCT06826261."},{"key":"ref_84","unstructured":"Borroni, B. (2025, October 09). Clinicaltrials.gov. At Home Gamma tACS in Alzheimer\u2019s Disease (tACS@Home) (tACS@Home), Available online: https:\/\/clinicaltrials.gov\/study\/NCT05643326."},{"key":"ref_85","unstructured":"Universit\u00e0 Degli Studi di Trento (2025, October 09). Clinicaltrials.gov. Noninvasive Brain Stimulation for pAD (pADmemory), Available online: https:\/\/clinicaltrials.gov\/study\/NCT05468268."},{"key":"ref_86","unstructured":"Universit\u00e0 Degli Studi di Trento (2025, October 09). Clinicaltrials.gov. Applying Non-invasive Brain Stimulation in Alzheimer\u2019s Rehabilitation (StimoLaMente), Available online: https:\/\/clinicaltrials.gov\/study\/NCT04866979."},{"key":"ref_87","unstructured":"Brignani, D. (2025, October 09). IRCCS Centro San Giovanni di Dio Fatebenefratelli. Clinicaltrials.gov. Network-based rTMS in Alzheimer\u2019s Disease, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04263194."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3233\/JAD-210659","article-title":"Targeting Default Mode Network Dysfunction in Persons at Risk of Alzheimer\u2019s Disease with Transcranial Magnetic Stimulation (NEST4AD): Rationale and Study Design","volume":"83","author":"Pievani","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13195-023-01297-4","article-title":"Home-based transcranial alternating current stimulation (tACS) in Alzheimer\u2019s disease: Rationale and study design","volume":"15","author":"Altomare","year":"2023","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_90","unstructured":"Alzheimer Europe (2025, November 17). European Dementia Monitor 2023. Available online: https:\/\/www.alzheimer-europe.org\/sites\/default\/files\/2023-12\/307767_ALZHEIMER%20EUROPE%20_European%20Dementia%20Monitor_2023_V7.pdf."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jalz.2016.04.007","article-title":"Alzheimer\u2019s disease research in Ibero America","volume":"12","author":"Snyder","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/1980-57642020dn14-030004","article-title":"Genetics of dementia: Insights from Latin America","volume":"14","author":"Ramos","year":"2020","journal-title":"Dement. Neuropsychol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Lopera, F., Custodio, N., Rico-Restrepo, M., Allegri, R.F., Barrientos, J.D., Garcia Batres, E., Calandri, I.L., Calero Moscoso, C., Caramelli, P., and Duran Quiroz, J.C. (2023). A task force for diagnosis and treatment of people with Alzheimer\u2019s disease in Latin America. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1198869"},{"key":"ref_94","first-page":"235","article-title":"Etiology, risk factors, treatments and current status of Alzheimer\u2019s disease in Mexico","volume":"158","year":"2022","journal-title":"Gac. Med. Mex."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1819.1999.00464.x","article-title":"Recent advances in dementia research in Japan: Alzheimer-type dementia","volume":"53","author":"Kosaka","year":"1999","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/alz.12380","article-title":"Alzheimer\u2019s disease research progress in Australia: The Alzheimer\u2019s Association International Conference Satellite Symposium in Sydney","volume":"18","author":"Sexton","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jocn.2020.09.018","article-title":"Recent advances in research on Alzheimer\u2019s disease in China","volume":"81","author":"Zhang","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3233\/JAD-200306","article-title":"Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer\u2019s Disease","volume":"78","author":"Marizzoni","year":"2020","journal-title":"J Alzheimer\u2019s Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1582-4934.2010.01038.x","article-title":"Gene therapy in Alzheimer\u2019s disease\u2014Potential for disease modification","volume":"14","author":"Nilsson","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4252\/wjsc.v12.i8.787","article-title":"Stem cell therapy for Alzheimer\u2019s disease","volume":"12","author":"Liu","year":"2020","journal-title":"World J. Stem. Cells."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2271613","DOI":"10.1080\/19490976.2023.2271613","article-title":"Gut microbiome-targeted therapies for Alzheimer\u2019s disease","volume":"15","author":"Zhang","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_102","unstructured":"Ministero Della Salute (2025, November 13). 21 Settembre, Giornata Mondiale Dell\u2019Alzheimer: L\u2019impegno Del Ministero Per Pazienti e Famiglie, Available online: https:\/\/www.salute.gov.it\/new\/it\/news-e-media\/notizie\/21-settembre-giornata-mondiale-dellalzheimer-limpegno-del-ministero-pazienti-e\/."},{"key":"ref_103","unstructured":"Osservatorio Demenze (2025, November 13). Fondo Per L\u2019Alzheimer e Le Demenze 2024\u20132026. Available online: https:\/\/www.demenze.it\/it-schede-10069-fondo_per_l_alzheimer_e_le_demenze_2024_2026."}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/17\/12\/196\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:23:40Z","timestamp":1764681820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/17\/12\/196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":103,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["neurolint17120196"],"URL":"https:\/\/doi.org\/10.3390\/neurolint17120196","relation":{},"ISSN":["2035-8377"],"issn-type":[{"value":"2035-8377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}